🇺🇸 FDA
Pipeline program

TAS-120

TAS-120-205

Phase 2 small_molecule active

Quick answer

TAS-120 for Advanced Cholangiocarcinoma is a Phase 2 program (small_molecule) at Taiho Pharma Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Taiho Pharma Netherlands B.V.
Indication
Advanced Cholangiocarcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials